(Q37886158)

24 August 2017

1 reference

title

Treatment of special populations with chronic hepatitis B infection (English)

1 reference

24 August 2017

1 reference

1 reference

Irene N Rapti

1

1 reference

24 August 2017

Stephanos J Hadziyannis

series ordinal

2

1 reference

24 August 2017

publication date

1 June 2011

1 reference

Expert Review of Gastroenterology & Hepatology

24 August 2017

published in

1 reference

24 August 2017

volume

5

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

323-339

1 reference

Special populations with hepatitis B virus infection

24 August 2017

cites work

1 reference

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

21 January 2018

1 reference

Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis

21 January 2018

1 reference

Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

Evolution of multi-drug resistant hepatitis B virus during sequential therapy

21 January 2018

1 reference

Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation

21 January 2018

1 reference

Telbivudine versus lamivudine in patients with chronic hepatitis B

21 January 2018

1 reference

Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma.

21 January 2018

1 reference

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

21 January 2018

1 reference

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

21 January 2018

1 reference

Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort

21 January 2018

1 reference

Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function

21 January 2018

1 reference

Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis.

21 January 2018

1 reference

Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis

21 January 2018

1 reference

Entecavir in decompensated HBV cirrhosis: the future is looking brighter

21 January 2018

1 reference

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.

21 January 2018

1 reference

Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy

21 January 2018

1 reference

Management of patients with decompensated hepatitis B virus associated [corrected] cirrhosis

21 January 2018

1 reference

Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors

21 January 2018

1 reference

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

21 January 2018

1 reference

Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma

21 January 2018

1 reference

Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis

21 January 2018

1 reference

Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy

21 January 2018

1 reference

Prophylaxis and treatment of hepatitis B in immunocompromised patients

21 January 2018

1 reference

Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies

21 January 2018

1 reference

Managing HBV in patients with impaired immunity

21 January 2018

1 reference

The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting

21 January 2018

1 reference

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy

21 January 2018

1 reference

Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy

21 January 2018

1 reference

A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial

21 January 2018

1 reference

Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy

21 January 2018

1 reference

Hepatology: a home for hepatocellular cancer publications

21 January 2018

1 reference

Outcome of liver transplantation for hepatitis B in the United States

21 January 2018

1 reference

Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective

21 January 2018

1 reference

Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease

21 January 2018

1 reference

Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence

21 January 2018

1 reference

Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis

21 January 2018

1 reference

A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis

21 January 2018

1 reference

Management of hepatitis B in liver transplant recipients

21 January 2018

1 reference

Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study

21 January 2018

1 reference

Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment

21 January 2018

1 reference

Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients

21 January 2018

1 reference

Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection

21 January 2018

1 reference

Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients

21 January 2018

1 reference

Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses

21 January 2018

1 reference

A forgotten population with chronic hepatitis C infection: subjects coinfected with hepatitis B virus

21 January 2018

1 reference

Hepatitis D virus infection--not a vanishing disease in Europe!

21 January 2018

1 reference

Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.

21 January 2018

1 reference

Treatment of chronic hepatitis delta with pegylated interferon-alpha2b

21 January 2018

1 reference

Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta

21 January 2018

1 reference

Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon

21 January 2018

1 reference

Epidemiology of viral hepatitis and HIV co-infection

21 January 2018

1 reference

Natural history of chronic hepatitis B in co-infected patients.

21 January 2018

1 reference

The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state

21 January 2018

1 reference

Management of hepatitis B in special patient populations

21 January 2018

1 reference

Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients

21 January 2018

1 reference

Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients

21 January 2018

1 reference

Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir

21 January 2018

1 reference

The HBV drug entecavir - effects on HIV-1 replication and resistance

21 January 2018

1 reference

The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients

21 January 2018

1 reference

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.

21 January 2018

1 reference

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

21 January 2018

1 reference

Hepatitis B and human immunodeficiency virus coinfection

21 January 2018

1 reference

Management of hepatitis B: summary of a clinical research workshop

21 January 2018

1 reference

Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae

21 January 2018

1 reference

Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience

21 January 2018

1 reference

The use of lamivudine for patients with acute hepatitis B (a series of cases).

21 January 2018

1 reference

Treating chronic hepatitis B infection in patients who are pregnant or are undergoing immunosuppressive chemotherapy

21 January 2018

1 reference

Clinical course of hepatitis B virus infection during pregnancy

21 January 2018

1 reference

Perinatal transmission of hepatitis B virus and its prevention

21 January 2018

1 reference

Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis

21 January 2018

1 reference

Hepatitis B mother--to--child transmission

21 January 2018

1 reference

Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy

21 January 2018

1 reference

A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG.

21 January 2018

1 reference

Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.

21 January 2018

1 reference

Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection

21 January 2018

1 reference

Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

Interruption of HBV intrauterine transmission: a clinical study

21 January 2018

1 reference

Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus--a systematic review

21 January 2018

1 reference

Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers

21 January 2018

1 reference

Clinical pharmacokinetics of lamivudine

21 January 2018

1 reference

Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial.

21 January 2018

1 reference

Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B.

21 January 2018

1 reference

Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options

21 January 2018

1 reference

Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation.

21 January 2018

1 reference

Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency

21 January 2018

1 reference

Entecavir therapy for adefovir-resistant hepatitis B virus infection in kidney and liver allograft recipients

21 January 2018

1 reference

Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis

21 January 2018

1 reference

Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients

21 January 2018

1 reference

Adefovir dipivoxil for wait-listed and post–liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.11.7

1 reference

24 August 2017

1 reference